SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 Replication

被引:15
|
作者
Paz, Sean [1 ]
Lu, Michael L. [1 ]
Takata, Hiroshi [2 ]
Trautmann, Lydie [2 ]
Caputi, Massimo [1 ]
机构
[1] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA
[2] Vaccine Gene Therapy Inst Florida, Port St Lucie, FL USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; SPLICING FACTOR SRSF1; SR PROTEINS; GENE-EXPRESSION; P-TEFB; MOLECULAR CLONE; POLYMERASE-II; NASCENT RNA; TYPE-1; TRANSCRIPTION;
D O I
10.1128/JVI.00693-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Replication of the integrated HIV-1 genome is tightly regulated by a series of cellular factors. In previous work we showed that transactivation of the HIV-1 promoter is regulated by the cellular splicing factor SRSF1. Here we report that SRSF1 can downregulate the replication of B, C, and D subtype viruses by >200-fold in a cell culture system. We show that viral transcription and splicing are inhibited by SRSF1 expression. Furthermore, SRSF1 deletion mutants containing the protein RNA-binding domains but not the arginine serine-rich activator domain can downregulate viral replication by >2,000-fold with minimal impact on cell viability and apoptosis. These data suggest a therapeutic potential for SRSF1 and its RNA-binding domains.
引用
收藏
页码:6275 / 6286
页数:12
相关论文
共 50 条
  • [41] REGULATION OF REPLICATION OF HIV-1
    HASELTINE, WA
    CONTROL OF HUMAN RETROVIRUS GENE EXPRESSION, 1988, : 135 - 158
  • [42] HIV-1 replication cycle
    Ferguson, MR
    Rojo, DR
    von Lindern, JJ
    O'Brien, WA
    CLINICS IN LABORATORY MEDICINE, 2002, 22 (03) : 611 - +
  • [43] Residual HIV-1 replication
    Pomerantz, RJ
    BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (01) : 13 - 15
  • [44] SRSF1 acts as an IFN-I-regulated cellular dependency factor decisively affecting HIV-1 post-integration steps
    Sertznig, Helene
    Roesmann, Fabian
    Wilhelm, Alexander
    Heininger, Delia
    Bleekmann, Barbara
    Elsner, Carina
    Santiago, Mario
    Schuhenn, Jonas
    Karakoese, Zehra
    Benatzy, Yvonne
    Snodgrass, Ryan
    Esser, Stefan
    Sutter, Kathrin
    Dittmer, Ulf
    Widera, Marek
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Unearthing a novel function of SRSF1 in binding and unfolding of RNA G-quadruplexes
    De Silva, Naiduwadura Ivon Upekala
    Lehman, Nathan
    Fargason, Talia
    Paul, Trenton
    Zhang, Zihan
    Zhang, Jun
    NUCLEIC ACIDS RESEARCH, 2024, 52 (08) : 4676 - 4690
  • [46] μ-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication
    Steele, AD
    Henderson, EE
    Rogers, TJ
    VIROLOGY, 2003, 309 (01) : 99 - 107
  • [47] Styrylquinoline derivatives:: A new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells
    Mekouar, K
    Mouscadet, JF
    Desmaële, D
    Subra, F
    Leh, H
    Savouré, D
    Auclair, C
    d'Angelo, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) : 2846 - 2857
  • [48] SPECIFIC HIV-1 INHIBITORS TARGETED AT THE HIV-1 RT
    DECLERCQ, E
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 673 - 673
  • [49] Molecular recognition of cyclic urea HIV-1 protease inhibitors
    Ala, PJ
    DeLoskey, RJ
    Huston, EE
    Jadhav, PK
    Lam, PYS
    Eyermann, CJ
    Hodge, CN
    Schadt, MC
    Lewandowski, FA
    Weber, PC
    McCabe, DD
    Duke, JL
    Chang, CH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) : 12325 - 12331
  • [50] Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease
    Martin, JL
    Begun, J
    Schindeler, A
    Wickramasinghe, WA
    Alewood, D
    Alewood, PF
    Bergman, DA
    Brinkworth, RI
    Abbenante, G
    March, DR
    Reid, RC
    Fairlie, DP
    BIOCHEMISTRY, 1999, 38 (25) : 7978 - 7988